<DOC>
	<DOCNO>NCT01274182</DOCNO>
	<brief_summary>The purpose study determine PK/PD , efficacy safety GP2013 patient severe rheumatoid arthritis .</brief_summary>
	<brief_title>GP2013 Treatment RA Patients Refractory Intolerant Standard Therapy</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Rheumatoid arthritis define 1987 ACR classification Severe active seropositive disease Inadequate response intolerance DMARDs antiTNFs Treatment Methotrexate Patients systemic manifestation rheumatoid arthritis Female patient nurse Women childbearing potential unless use birth control Active infection Known immunodeficiency syndrome Positive Hepatitis B surface antigen antibody Hepatitis C History cancer Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>